On the other hand, butyrate administrated 2 weeks prior to DSS-induced colitis (group 4) tended to increase the plasmatic level of anti-inflammatory cytokine IL-10 compared to the DSS group (Figure 3C). The gene discussed is IL10; the disease is colitis.